Mn Services Vermogensbeheer B.V. Acquires 400 Shares of Waters Co. (NYSE:WAT)

Mn Services Vermogensbeheer B.V. raised its holdings in Waters Co. (NYSE:WATFree Report) by 1.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 23,033 shares of the medical instruments supplier’s stock after buying an additional 400 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Waters were worth $8,545,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. New York Life Investment Management LLC grew its position in shares of Waters by 1.2% in the 4th quarter. New York Life Investment Management LLC now owns 8,910 shares of the medical instruments supplier’s stock worth $3,305,000 after buying an additional 108 shares during the last quarter. FourThought Financial Partners LLC bought a new stake in shares of Waters in the 4th quarter worth approximately $232,000. Impax Asset Management Group plc grew its position in shares of Waters by 10.6% in the 4th quarter. Impax Asset Management Group plc now owns 714,155 shares of the medical instruments supplier’s stock worth $264,937,000 after buying an additional 68,509 shares during the last quarter. Rothschild Investment LLC boosted its position in shares of Waters by 23.1% during the fourth quarter. Rothschild Investment LLC now owns 293 shares of the medical instruments supplier’s stock valued at $109,000 after purchasing an additional 55 shares in the last quarter. Finally, Crestwood Advisors Group LLC boosted its position in shares of Waters by 6.3% during the fourth quarter. Crestwood Advisors Group LLC now owns 1,026 shares of the medical instruments supplier’s stock valued at $381,000 after purchasing an additional 61 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Up 1.1 %

WAT stock opened at $377.22 on Friday. Waters Co. has a 1-year low of $279.24 and a 1-year high of $423.56. The business has a fifty day moving average price of $390.04 and a 200-day moving average price of $367.30. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The stock has a market capitalization of $22.40 billion, a P/E ratio of 35.22, a P/E/G ratio of 3.79 and a beta of 1.01.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Equities analysts forecast that Waters Co. will post 12.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. TD Cowen lifted their price target on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Stifel Nicolaus lifted their price target on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. lifted their price target on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Scotiabank upgraded Waters from a “sector perform” rating to a “sector outperform” rating and lifted their price target for the company from $430.00 to $450.00 in a research report on Thursday, February 13th. Finally, Wells Fargo & Company lifted their price target on Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. Eleven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $390.40.

Get Our Latest Stock Analysis on WAT

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.